Coordination Funds
Coordination Funds
批准号:
174860066
负责人:
Professor Dr. Michael Lübbert, Ph.D.
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
2010
资助国家:
德国
项目状态:
已结题
起止时间:
2009-12-31 至 2017-12-31
关键词:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In July 2009, the Senate of the Deutsche Forschungsgemeinschaft (DFG of German Research Foundation) announced the establishment of a new Priority Program on “Epigenetic regulation of normal hematopoiesis and its dysregulation in myeloid neoplasia”. In May 2010, an international review panel selected 15 research projects for funding within the project. This program brings basic and clinical research in Germany together and supports highly interactive projects in epigenetic research as well as in the development of novel epigenetic therapies. The program has two co-coordinators, Dr. Michael Lübbert in Freiburg and Dr. Christoph Plass in Heidelberg and includes a coordinating central project which supports internal and international activities between the members of the central project. Here we request funds for continuation of the coordinating Central Project for Priority Program. These funds will support the coordinators of the project with three major tasks: Task 1 will be to coordinate the daily work and communication in the Priority Program. Task 2 will be to provide support to the coordinators in promoting scientific advances from the Program on a national as well as international level. Task 3 is devoted to equal opportunities for female scientists and single parents with children.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Combined epigenetic therapy of acute myeloid leukemia: translational studies of in vivo induction of gene expression and DNA hypomethylation
-
批准号:172102549
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Professor Dr. Michael Lübbert, Ph.D.
-
依托单位:
Funktionelle Rolle von Cytosin-Demethylierung in der transkriptionellen Regulation myeloischer Differenzierung
-
批准号:5228002
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2000
-
负责人:Professor Dr. Michael Lübbert, Ph.D.
-
依托单位:
Prospective randomized multicenter phase III trial of decitabine and Venetoclax administered in combination with all-trans retinoic acid or placebo in patients with acute myeloid leukemia who are ineligible for induction chemotherapy
-
批准号:367848349
-
项目类别:Clinical Trials
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Michael Lübbert, Ph.D.
-
依托单位:
Coordination Funds
-
批准号:388216676
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Michael Lübbert, Ph.D.
-
依托单位:
海外基金